Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹2,308 Cr
Revenue (TTM)
₹451 Cr
Net Profit (TTM)
₹70 Cr
ROE
29.8 %
ROCE
33.3 %
P/E Ratio
33
P/B Ratio
7
Industry P/E
44.5
EV/EBITDA
16.2
Div. Yield
0.1 %
Debt to Equity
0.5
Book Value
₹686.7
EPS
₹146.5
Face value
10
Shares outstanding
4,832,827
CFO
₹464.17 Cr
EBITDA
₹514.17 Cr
Net Profit
₹200.34 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr Agarwals Hosp
| -10.5 | 0.0 | -13.0 | 10.1 | 70.5 | 67.7 | 38.2 |
|
BSE Healthcare*
| -2.8 | -2.6 | -2.9 | 4.3 | 25.1 | 15.7 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dr Agarwals Hosp
| -17.6 | 121.5 | 132.4 | 81.1 | 143.9 | -7.4 | -28.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dr Agarwals Hosp
|
4,776.3 | 2,308.3 | 450.7 | 69.9 | 22.1 | 26.7 | 33 | 7.0 |
| 225.6 | 3,655.3 | 1,041.9 | 96.4 | 12.0 | 11.5 | 37.8 | 3.1 | |
| 652.6 | 34,286.7 | 4,461.2 | 397.5 | 13.4 | 9.1 | 104.9 | 7.5 | |
| 424.9 | 13,736.8 | 1,976.2 | 160.7 | 14.1 | 6.7 | 109 | 7.0 | |
| 561.3 | 8,470.7 | 2,478.2 | 24.7 | 8.4 | 4.2 | 447 | 6.3 | |
| 394.6 | 3,724.7 | 1,451.5 | 182.9 | 15.5 | 29.2 | 20.4 | 5.3 | |
| 1,275.2 | 8,393.4 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.5 | 5.6 | |
| 5,212.1 | 5,798.5 | 1,529.9 | 235.8 | 21.2 | 20.7 | 24.6 | 4.6 | |
| 1,112.2 | 11,410.7 | 1,613.3 | 259.9 | 23.0 | 17.3 | 44.3 | 7.2 | |
| 661.7 | 6,489.5 | 1,089.4 | 165.1 | 17.4 | 10.2 | 38.8 | 3.7 |
No Review & Analysis are available.
Dr. Agarwal's Eye Hospital Limited operates hospitals, nursing homes, clinics, medical and research facilities, and other institutions for eye care and treatment in India and internationally. The company offers services in the areas of cataract,... glaucoma, laser correction, cornea and refractive, retina, squint, pediatric and neuro ophthalmology, uvea, and orbit and oculoplasty, as well as provides other health related services. It is also involved in the operation of other health care facilities; and hospital related trading and other activities. The company was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited is a subsidiary of Dr. Agarwal's Health Care Limited. Read more
Incorporated
1994
Chairman
Amar Agarwal
Managing Director
Amar Agarwal
Headquarters
Chennai, Tamil Nadu
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Dr Agarwals Eye Hospital Ltd is ₹4,776.25 (BSE) as of 18-Mar-2026 IST. Dr Agarwals Eye Hospital Ltd has given a return of 70.46% in the last 3 years.
The P/E ratio of Dr Agarwals Eye Hospital Ltd is 33.05 times as on 18-Mar-2026, a 26 discount to its peers’ median range of 44.50 times.
The P/B ratio of Dr Agarwals Eye Hospital Ltd is 6.96 times as on 18-Mar-2026, a 5 premium to its peers’ median range of 6.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
34.85
|
9.09
|
|
2024
|
31.46
|
9.28
|
|
2023
|
11.65
|
3.80
|
|
2022
|
14.26
|
4.39
|
|
2021
|
0.00
|
2.69
|
The 52-week high and low of Dr Agarwals Eye Hospital Ltd are Rs 6,392.00 and Rs 3,750.00 as of 19-Mar-2026.
Dr Agarwals Eye Hospital Ltd has a market capitalisation of ₹ 2,308 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Dr Agarwals Eye Hospital Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹73.00
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.